溶栓
医学
神经保护
药物输送
血栓
组织纤溶酶原激活剂
冲程(发动机)
血小板
药理学
血小板活化
脑缺血
基因传递
内科学
缺血
生物医学中的光声成像
脑血流
心脏病学
血流
溶栓药
药品
纤溶剂
麻醉
纤溶酶原激活剂
作者
Mengtao Han,Haoming Zhong,Yuling Zhang,Min Zhang,Yaguang Ren,Zhiqiang Xu,Lu Ling,Zhiwei Xue,Yiming He,Chengbo Liu,Yizhou Tan,Lingyan Zhang,Jingqin Chen,Donghai Wang
出处
期刊:iScience
[Cell Press]
日期:2026-01-23
卷期号:29 (2): 114777-114777
被引量:3
标识
DOI:10.1016/j.isci.2026.114777
摘要
Acute ischemic stroke (AIS) is a major cause of disability and mortality worldwide, typically resulting from a thrombus that blocks cerebral blood flow. Current treatments focus on thrombolysis and neuroprotection, with recombinant tissue plasminogen activator (rt-PA) and edaravone (Eda) as key drugs. However, their therapeutic efficacy is constrained by poor targeting, leading to suboptimal drug delivery to the brain. Herein, we develop a biomimetic delivery system (PLEA, platelet membrane-liposome hybrid delivery system encapsulating Eda and rt-PA) by hybridizing platelet membranes with liposomes, leveraging natural thrombus-targeting ability of the platelet membrane to enhance drug delivery efficiency. PLEA effectively targeted thrombus sites, synchronously enhancing thrombolysis and providing neuroprotection in a mouse model of AIS. Photoacoustic (PA) imaging was used to monitor clot formation and assess changes in intracranial blood flow and oxygen levels. These findings indicate that PA imaging-guided PLEA treatment represents a promising approach for precise stroke treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI